Gain of von Willebrand factor-binding function by mutagenesis of a species-conserved residue within the leucine-rich repeat region of platelet glycoprotein Ibα

Blood

Volumn 106, Issue 6, 2005, Pages 1982-1987

  Peng, Yuandong ^a   Shrimpton, Corie N ^a   Dong, Jing Fei ^a   López, José A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTROCETIN; GLYCOPROTEIN IB ALPHA; LEUCINE; RISTOCETIN; VON WILLEBRAND FACTOR;

ALLOSTERISM; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CHO CELL; DOG; FLOW MEASUREMENT; HUMAN; MOUSE; MUTAGENESIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN FUNCTION; SPECIES CONSERVATION; SURFACE PROPERTY; THROMBOCYTE;

EID: 24744464589     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2005-02-0514     Document Type: Article

References (27)

1. Dong J, Schade AJ, Romo GM, et al. Novel gain-of-function mutations of platelet glycoprotein Ibα by valine mutagenesis in the Cys209-Cys248 disulfide loop: functional analysis under statis and dynamic conditions. J Biol Chem. 2000;275: 27663-27670.
2. Huizinga EG, Tsuji S, Romijn RA, et al. Structures of glycoprotein Ibα and its complex with von Willebrand factor A1 domain. Science. 2002;297: 1176-1179.
3. Afshar-Kharghan V, Gineys G, Schade AJ, et al. Necessity of conserved asparagine residues in the leucine-rich repeats of platelet glycoprotein Ibα for the proper conformation and function of the ligand-binding region. Biochemistry. 2000;39:3384-3391.
4. Miller JL, Lyle VA, Cunningham D. Mutation of leucine-57 to phenylalanine in a platelet glycoprotein Ibα leucine tandem repeat occurring in patients with an autosomal dominant variant of Bernard-Soulier disease. Blood. 1992;79:439-446.
5. Kenny D, Jonsson O, Moratech P, Montgomery R. Naturally occurring mutations in glycoprotein Ibα that result in defective ligand binding and synthesis of a truncated protein. Blood. 1999;92:175-184.
6. De Marco L, Mazzucato M, Fabris F, et al. Variant Bernard-Soulier syndrome type Bolzano: a congenital bleeding disorder due to a structural and functional abnormality of the platelet glycoprotein Ib-IX complex. J Clin Invest. 1990;86:25-31.
7. Ware J, Russell SR, Marchese P, et al. Point mutation in a leucine-rich repeat of platelet glycoprotein Ibα resulting in the Bernard-Soulier syndrome. J Clin Invest. 1993;92:1213-1220.
8. López JA, Leung B, Reynolds CC, Li CQ, Fox JEB. Efficient plasma membrane expression of a functional platelet glycoprotein Ib-IX complex requires the presence of its three subunits. J Biol Chem. 1992;267:12851-12859.
9. López JA, Weisman S, Sanan DA, et al. Glycoprotein (GP) Ibβ is the critical subunit linking GP Ibα and GP IX in the GP Ib-IX complex: analysis of partial complexes. J Biol Chem. 1994;269: 23716-23721.
10. Ward CM, Andrews RK, Smith AI, Berndt MC. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibα: identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibα as a binding site for von Willebrand factor and α-thrombin. Biochemistry. 1996; 35:4929-4938.
11. Berndt MC, Du X, Booth WJ. Ristocetin-dependent reconstitution of binding of von Willebrand factor to purified human platelet membrane glycoprotein Ib-IX complex. Biochemistry. 1988;27: 633-640.
12. Peng Y, Berndt MC, Cruz MA, Lopez JA. The α1 Helix-β13 strand spanning Leu214-Val229 of platelet glycoprotein Ibα facilitates the interaction with von Willebrand factor: evidence from characterization of the epitope of monoclonal antibody AP1. Blood. 2004;104:3971-3978.
13. Azuma H, Sugimoto M, Ruggeri ZM, Ware J. A role for von Willebrand factor proline residues 702-704 in ristocetin-mediated binding to platelet glycoprotein Ib. Thromb Haemost. 1993;69:192-196.
14. Shen Y, Romo GM, Dong J, et al. Requirement of leucine-rich repeats of glycoprotein (GP) Ibα for shear-dependent and static binding of von Willebrand factor to the platelet membrane GP Ib-IX-V complex. Blood. 2000;95:903-910.
15. Dong JF, Berndt MC, Schade A, et al. Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent interactions. Blood. 2001;97:162-168.
16. Fredrickson BJ, Dong JF, McIntire LV, López JA. Shear-dependent rolling on von Willebrand factor of mammalian cells expressing the platelet glycoprotein Ib-IX-V complex. Blood. 1998;92:3684-3693.
17. Lawrence MB, McIntire LV, Eskin SG. Effect of flow on polymorphonuclear leukocyte/endothelial cell adhesion. Blood. 1987;70:1284-1290.
18. Kukreti S, Konstantopoulos K, Smith CW, McIntire LV. Molecular mechanisms of monocyte adhesion to interleukin-1β-stimulated endothelial cells under physiologic flow conditions. Blood. 1997;89:4104-4111.
19. Ruan C, Du X, Xi X, Castaldi PA, Berndt MC. A murine antiglycoprotein Ib complex monoclonal antibody, SZ 2, inhibits platelet aggregation induced by both ristocetin and collagen. Blood. 1987;69:570-577.
20. Ruan C, Tobelem G, McMichael AJ, et al. Monoclonal antibody to human platelet glycoprotein I, II: effects on human platelet function. Br J Haematol. 1981;49:511-519.
21. Marchese P, Murata M, Mazzucato M, et al. Identification of three tyrosine residues of glycoprotein Ibα with distinct roles in von Willebrand factor and α-thrombin binding. J Biol Chem. 1995;270:9571-9578.
22. Dong J, Ye P, Schade AJ, et al. Tyrosine sulfation of glycoprotein Ibα: role of electrostatic interactions in von Willebrand factor binding. J Biol Chem. 2001;276:16690-16694.
23. Miller JL, Castella A. Platelet-type von Willebrand's disease: characterization of a new bleeding disorder. Blood. 1982;60:790-794.
24. Dumas JJ, Kumar R, McDonagh T, et al. Crystal structure of the wild-type von Willebrand factor A1-glycoprotein Ibα complex reveals conformation differences with a complex bearing von Willebrand disease mutations. J Biol Chem. 2004;279: 23327-23334.
25. Uff S, Clemetson JM, Harrison T, Clemetson KJ, Emsley J. Crystal structure of the platelet glycoprotein Ibα N-terminal domain reveals an unmasking mechanism for receptor activation. J Biol Chem. 2002;277:35657-35663.
26. Othman M, Notley C, Lavender FL, et al. Identification and functional characterization of a novel 27-bp deletion in the macroglycopeptide-coding region of the GPIbα gene resulting in platelet-type von Willebrand disease. Blood. 2005;105: 4330-4336.
27. Shimizu A, Matsushita T, Kondo T, et al. Identification of the amino acid residues of the platelet glycoprotein Ib (GPIb) essential for the von Willebrand factor binding by clustered charged-to-alanine scanning mutagenesis. J Biol Chem. 2004; 279:16285-16294.